Atrial fibrillation

Emerg Med Clin North Am. 2011 Nov;29(4):747-58, vi. doi: 10.1016/j.emc.2011.08.008. Epub 2011 Sep 29.

Abstract

Atrial fibrillation (AF) results from the chaotic depolarization of atrial tissue and is the most common dysrhythmia diagnosed in United States (US) emergency departments. AF affects greater than 1% of the general population, with a peak prevalence of 10% in those greater than 80 years of age. By 2050, it is estimated that nearly 16 million US patients will suffer from AF. AF has significant health effects, and places a considerable economic burden on the health care system. This article discusses recommendations that are derived from a combination of existing guidelines, additional evidence, and consensus.

Publication types

  • Review

MeSH terms

  • Anti-Arrhythmia Agents / therapeutic use
  • Anticoagulants / therapeutic use
  • Atrial Fibrillation / diagnosis*
  • Atrial Fibrillation / therapy*
  • Electric Countershock
  • Emergency Service, Hospital*
  • Fibrinolytic Agents / therapeutic use
  • Heparin / therapeutic use
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans

Substances

  • Anti-Arrhythmia Agents
  • Anticoagulants
  • Fibrinolytic Agents
  • Heparin, Low-Molecular-Weight
  • Heparin